IBD Drugs 'Prohibitively' Expensive for Medicare Patients

Over their lifetime, Medicare patients with IBD can expect to shell out tens to hundreds of thousands of dollars in out-of-pocket costs for needed medications.
Medscape Medical News

source https://www.medscape.com/viewarticle/982908?src=rss

Comments

Popular posts from this blog